Oncimmune Appoints CMO
This article was originally published in Scrip
Executive Summary
Oncimmune, a leader in early cancer detection, has named Dr. James Jett chief medical officer. Jett is currently professor of medicine in the division of oncology at National Jewish Health in the US, where his research includes conducting clinical trials related to the screening and early detection of lung cancer. Prior to joining National Jewish Health in 2010, he held appointments as professor of medicine at Mayo Medical School and the University of Pittsburgh.